3D Printing Technology in Pharmaceuticals and Biomedical: A Review
3D printing is also known as additive manufacturing, which is the potential way to transform the manufacturing as well formulation in pharmaceuticals and biomedical industries. Three-dimensional (3D) Printed medicines are revolutionsing the pharmaceutical market as potential tools to achieve personalized treatments adapted to the specific requirements of each patient, taking into account their age, weight, comorbidities, pharmacogenetic, and pharmacokinetic characteristics. Additive manufacturing or 3D printing has wide range of techniques which are classified in many categories but most commonly used in the 3D printing of medicines are: printing-based inkjet systems, nozzle-based deposition systems, and laser-based writing systems, in addition to both polymer filaments and hydrogels as materials for drug carriers.
Keywords: 3D printing, Additive Manufacturing, Bioprinting, Drug delivery, Medical devices
2. Assraa H Jassim-Jaboori and Moses O Oyewumi,” 3D Printing Technology in Pharmaceutical Drug Delivery: Prospects and Challenges” journal of Biomolecular Research & Therapeutics, 4(4):1000e141.
3. Ameya Chaudhari, Jay Patel, Suyash Oka &Manish Jain,” 3d Printing in the Pharmaceutical and Biomedical Industries” International Journal of Engineering Research, 7(5):78-81.
4. Eric Lepowsky & Savas Tasoglu,” 3D printing for drug manufacturing: A perspective on the future of pharmaceuticals” International Journal of Bioprinting 2018; 4(1):1-13.
5. Ion-Bogdan Dumitrescu& Dumitru Lupuliasa,” The Age of Pharmaceutical 3D Printing Technological and Therapeutical Implications of Additive Manufacturing” Farmacia, 2018; 66(3):365-389.
6. Diogo José Horst,” 3D Printing of Pharmaceutical Drug Delivery Systems” Archives of Organic and Inorganic Chemical Sciences, 2018; 1(2):65-69.
7. Giovanny F. Acosta-Vélez & Benjamin M. Wu,” 3D Pharming: Direct Printing of Personalized Pharmaceutical Tablets” Polymer Sciences. 2016, 1:2.
8. Monisha Bansal, Varun Sharma, Gurfateh Singh, S. L. Harikumar,” 3d Printing for The Future of Pharmaceuticals Dosages Forms” International Journal of App Pharm, 2018; 10(3):1-7.
9. Karim Osouli-Bostanabad & Khosro Adibkia,” Made-on-demand, complex and personalized 3D-printed drug Products” BioImpacts, 2018, 8(2), 77-79
10. Andrea Alice Konta, Marta García-Piña & Dolores R. Serrano,” Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?” Bioengineering 2017; 4(79):1-16.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).